Bis-pyridylpyridones as melaninconcentrating hormone receptor 1 antagonists

Details for Australian Patent Application No. 2008335187 (hide)

Owner Glaxo Group Limited

Inventors Blackwell III, William C.; Boros, Eric; Collins, Jon L; Ray, John; Hertzog, Don; Samano, Vicente; Reister, Steven Michael; Liang, Xi; Allen, Scott; Sherrill, Ron

Agent Davies Collison Cave

Pub. Number AU-B-2008335187

PCT Pub. Number WO2009/076387

Priority 61/012,525 10.12.07 US

Filing date 10 December 2008

Wipo publication date 18 June 2009

Acceptance publication date 29 March 2012

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 5/04 (2006.01) Drugs for disorders of the endocrine system

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/076387 Priority application(s): WO2009/076387

29 March 2012 Application Accepted

  Published as AU-B-2008335187

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335195-Process for the conversion of ethane or mixed lower alkanes to aromatic hydrocarbons

2008335178-Methods for sequential replacement of targeted region by homologous recombination